Popular ergogenic drugs and supplements in young athletes

Pediatrics

Volumn 117, Issue 3, 2006, Pages

  Calfee, Ryan ^a   Fadale, Paul ^a,b  

^a BROWN UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Adolescent health; Athletes; Drug abuse use; Nutritional supplements; Steroids

Indexed keywords

ALKALOID DERIVATIVE; ANABOLIC AGENT; ANDROGEN; ANDROSTENEDIONE; BOLDENONE UNDECENOATE; CAFFEINE; CREATINE; EPHEDRA ALKALOID; EPHEDRINE; ERGOGENIC DRUG; GLUCOCORTICOID; GROWTH HORMONE; HORMONE PRECURSOR; METABOLIFE 356; METANDIENONE; NANDROLONE DECANOATE; NANDROLONE PHENPROPIONATE; OXANDROLONE; OXYMETHOLONE; PRASTERONE; PSEUDOEPHEDRINE; RIPPED FUEL; STANOZOLOL; STRYCHNINE; TESTOSTERONE CIPIONATE; UNCLASSIFIED DRUG; HUMAN GROWTH HORMONE; STREET DRUG;

ACROMEGALY; AGGRESSION; ANXIETY; ATHEROSCLEROSIS; ATHLETE; BODY MASS; BONE DISEASE; CEREBROVASCULAR ACCIDENT; CHOLESTASIS; CLINICAL TRIAL; COMPROMISED RENAL FUNCTION; CONTROLLED CLINICAL TRIAL; DEHYDRATION; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG COST; DRUG DEPENDENCE; DRUG EXCRETION; DRUG EXPOSURE; DRUG FATALITY; DRUG MARKETING; DRUG MECHANISM; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG USE; EPIPHYSIOLYSIS; ESTRADIOL BLOOD LEVEL; ESTRONE BLOOD LEVEL; FEMUR EPIPHYSIS; FOCAL GLOMERULOSCLEROSIS; GASTROINTESTINAL SYMPTOM; GLUCOSE INTOLERANCE; GYNECOMASTIA; HEART ARRHYTHMIA; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEPATITIS B; HEPATITIS C; HIGH SCHOOL STUDENT; HISTORY OF MEDICINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPERTENSION; INFERTILITY; INSOMNIA; INTRACRANIAL HYPERTENSION; JAW DISEASE; JAW ENLARGEMENT; KIDNEY DYSFUNCTION; LEGAL ASPECT; LIVER CELL CARCINOMA; LIVER CYST; LOADING DRUG DOSE; MEDICAL LITERATURE; MOOD CHANGE; MORBIDITY; MULTIPLE CYCLE TREATMENT; MULTIPLE ORGAN FAILURE; MUSCLE CRAMP; MYOPATHY; NONHUMAN; NUTRITIONAL SUPPORT; PAPILLEDEMA; PARANOID PSYCHOSIS; PELIOSIS HEPATIS; PHYSEAL CLOSURE; PRIAPISM; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PSYCHOSIS; RECOMMENDED DRUG DOSE; REVIEW; RISK ASSESSMENT; SEGMENTAL GLOMERULOSCLEROSIS; SEIZURE; SIDE EFFECT; SOCIAL ASPECT; SPORT; SUPPLEMENTATION; TACHYCARDIA; TESTIS ATROPHY; TESTOSTERONE BLOOD LEVEL; TREMOR; VIRILIZATION; WEIGHT REDUCTION; ADOLESCENT; AFFECT; ARTICLE; DIET SUPPLEMENTATION; DOPING; DRUG EFFECT; DRUG LEGISLATION; PSYCHOLOGICAL ASPECT; SPORTS MEDICINE; STATISTICS; SUBSTANCE ABUSE; UNITED STATES;

ADOLESCENT; AFFECT; AGGRESSION; ANABOLIC AGENTS; CREATINE; DEHYDROEPIANDROSTERONE; DIETARY SUPPLEMENTS; DOPING IN SPORTS; EPHEDRINE; HUMAN GROWTH HORMONE; HUMANS; LEGISLATION, DRUG; SPORTS MEDICINE; STREET DRUGS; SUBSTANCE ABUSE DETECTION; UNITED STATES;

EID: 33645017344     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-1429     Document Type: Review

References (105)

1. Grunbaum JA, Kann L, Kinchen SA, et al. Youth risk behavior surveillance: United States, 2003. MMWR Surveill Summ. 2004;53:1-96
2. Buckley WE, Yesalis CE, Friedl KE, et al. Estimated prevalence of anabolic steroid use among male high school seniors. JAMA. 1988;260:3441-3445
3. Silver MD. Use of ergogenic aids by athletes. J Am Acad Orthop Surg. 2001;9:61-70
4. Cogeni J, Miller S. Supplements and drugs used to enhance athletic performance. Pediatr Clin North Am. 2002;49:435-461
5. Rickert VI, Pawlak-Morello C, Sheppard V, et al. Human growth hormone: a new substance of abuse among adolescents? Clin Pediatr (Phila). 1992;31:723-736
6. Demorest RA, Bernhardt DT, Best TM, Landry GL. Pediatric residence education: is sports medicine getting its fair share? Pediatrics. 2005;115:28-33
7. Grivetti LE, Applegate EA. From Olympia to Atlanta: a cultural historical perspective on diet and athletic training. J Nutr. 1997;127(suppl):860- 868
8. Hoberman JM, Yesalis CE. The history of synthetic testosterone. Sci Am. 1995;272:76-81
9. McDevitt ER. Ergogenic drugs in sports. In: DeLee J, Drez D, eds. Orthopaedic Sports Medicine: Principles and Practice. 2nd ed. Philadelphia, PA: WB Saunders; 2003:471-483
10. Sturmi JE, Diorio DJ. Anabolic agents. Clin Sports Med. 1998;17:261-282
11. Williams MH. The use of nutritional ergogenic aids in sports: is it an ethical issue? Int J Sport Nutr. 1994;4:120-131
12. Voy R. Drugs, Sport and Politics. Champaign, IL: Leisure Press; 1990
13. Yesalis CE, ed. Anabolic Steroids in Sport and Exercise. Champaign, IL: Kinetic Publishers; 1993:35-47
14. Bamberger M, Yaeger D. Over the edge: special report. Sports Illustrated. 1997;86:64
15. Adler J. Toxic strength. Newsweek. 2004;Dec 20:44-52
16. Scelfo J, Johnson D. Texas, football, and juice. Newsweek. 2005;Mar 7:46-47
17. Fainaru-Wada M. Dreams, steroids, death: a ballplayer's downfall. San Francisco Chronicle 2004;Dec 19:A1
18. Yesalis C, Bahrke M. Doping among adolescent athletes. Clin Endocrinol Metab. 2000;14:25-35
19. Gorman C. Girls on steroids: among young athletes these dangerous drugs are the rage: is your daughter using them? Time. 1998;Aug 10:93
20. Tokish JM, Kocher MS, Hawkins RJ. Ergogenic aids: a review of basic science, performance, side effects, and status in sports. Am J Sports Med. 2004;32:1543-1553
21. Cable NT. Anabolic-androgenic steroids: ergogenic and cardiovascular effects. In: Reilly T, Orme M, eds. The Clinical Pharmacology of Sport and Exercise. Amsterdam, Netherlands: Excerpta Medica; 1997:135-144
22. Wilson JD. Androgens. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's the Pharmacological Basis of Therapeutics. New York, NY: McGraw-Hill; 1996:1441-1457
23. Haupt HA, Rovere GD. Anabolic steroids: a review of the literature. Am J Sports Med. 1984;12:469-484
24. Wilson JD. Androgen abuse by athletes. Endocr Rev. 1988;9:181-199
25. American Academy of Pediatrics Committee on Sports Medicine and Fitness. Adolescents and anabolic steroids: a subject review. Pediatrics. 1997;99:904-908
26. Bhasin S, Storer TW, Berman N, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996;335:1-7
27. Forbes GB, Porta CR, Herr BE, et al. Sequence of changes in body composition induced by testosterone and reversal of changes after the drug is stopped. JAMA. 1992;267:397-399
28. Giorgi A, Weatherby RP, Murphy PW. Muscular strength, body composition, and health responses to the use of testosterone enanthate: a double blind study. J Sci Med Sport. 1999;2:341-355
29. American College of Sports Medicine. Position statement on anabolic-androgenic steroids in sports. Med Sci Sports Exerc. 1987;19:534-539
30. Blazevich AJ, Giorgi A. Effect of testosterone administration and weight training on muscle architecture. Med Sci Sports Exerc. 2001;33:1688-1693
31. Kadi F, Eriksson A, Holmner S, Thornell L. Effects of anabolic steroids on the muscle cells of strength trained athletes. Med Sci Sports Exerc. 1999;31:1528-1534
32. Glazer G. Atherogenic effects of anabolic steroids on serum lipid levels: a literature review. Arch Intern Med. 1991;151:1925-1933
33. Riebe D, Fernhall B, Thompson PD. The blood pressure response to exercise in anabolic steroid users. Med Sci Sports Exerc. 1992;24:633-637
34. Blue JG, Lombardo JA. Steroids and steroid-like compounds. Clin Sports Med. 1999;18:667-689
35. Haupt HA. Anabolic steroids and growth hormone. Am J Sports Med. 1993;21:468-474
36. Michna H. Tendon injuries induced by exercise and anabolic steroids in experimental mice. Int Orthop. 1987;11:157-162
37. Rich JD, Dickinson BP, Feller A, et al. The infectious complications of anabolic-androgenic steroid injection. Int J Sports Med. 1999;20:563-566
38. Melia P, Pipe A, Greenberg L. The use of anabolic-androgenic steroids by Canadian students. Clin J Sport Med. 1996;6:9-14
39. Copeland J, Peters R, Dillon P. Anabolic-androgenic steroid use disorders among a sample of Australian competitive and recreational users. Drug Alcohol Depend. 2000;60:91-96
40. Middleman AB, Faulkner AH, Woods ER, Emans SJ, Durant RH. High risk behaviors among high school students in Massachusetts who use anabolic steroids. Pediatrics. 1995;96:268-272
41. DuRant RH, Escobedo LG, Heath GW. Anabolic-steroid use, strength training, and multiple drug use among adolescents in the United States. Pediatrics. 1995;96:23-28
42. Stilger VG, Yesalis CE. Anabolic-androgenic steroid use among high school football players. J Community Health. 1999;24:131-145
43. Faigenbaum AD, Zaichowsky LD, Gardner DE, Micheli LJ. Anabolic steroid use by male and female middle school students. Pediatrics. 1998;101(5). Available at: www.pediatrics.org/cgi/content/full/101/5/e6
44. Gray M. Youth athletes and anabolic steroid usage. Med Sci Sports Exerc. 1990;22:S63
45. Durant RH, Rickert VI, Ashworth CS, et al. Use of multiple drugs among adolescents who use anabolic steroids. N Engl J Med. 1993;328:922-926
46. US Department of Health and Human Services. Monitoring the Future Study, Overview of Key Findings; 2004. Available at: www.monitoringthefuture.org. Accessed January 20, 2006
47. Dezelsky TL, Toohey JV, Shaw RS. Non-medical drug use behavior at five United States universities: a 15 year study. Bull Narc. 1989;37:49-53
48. NCAA Study of Substance Use Habits of College Student-Athletes; 2001. Available at: www.ncaa.org/library/research.html#substance_use_habits. Accessed January 20, 2006
49. Berning JM, Adams KJ, Bryant SA, et al. Prevalence and perceived prevalence of anabolic steroid use among college-aged students. Med Sci Sports Exerc. 2004;36:S350
50. Arlt W. Adrenal Androgens. Endotext.com. Available at: www.endotext.org/aging/aging12/aging12.htm. Accessed January 20, 2006
51. Williams MH. The Ergogenic Edge: Pushing the Limits of Sports Performance. Champaign, IL: Human Kinetics; 1998
52. Johnson WA, Landry GL. Nutritional supplements: fact vs. fiction. Adolesc Med. 1998;9:501-513
53. Mahesh VB, Greenblatt RB. The in vivo conversion of dehydroepiandrosterone and androstenedione to testosterone in the human. Acta Endocrinol. 1962;41:400-406
54. Leder BZ, Longcope C, Catlin DH, et al. Oral androstenedione administration and serum testosterone concentrations in young men. JAMA. 2000;283:779-782
55. King DS, Sharp RL, Vukovich MD, et al. Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized controlled trial. JAMA. 1999;281:2020-2028
56. Broeder CE, Quindry J, Brittingham K, et al. The Andro Project: physiologic and hormonal influences of androstenedione supplementation in men 35 to 65 years old participating in a high-intensity resistance training program. Arch Intern Med. 2000;160:3093-3104
57. Kachhi PN, Henderson SO. Priapism after androstenedione intake for athletic performance enhancement. Ann Emerg Med. 2000;35:391-393
58. Habernicht UP, Schwarz K, Neumann F, et al. Induction of estrogen related hyperplastic changes in the prostate of the cynomolgus monkey (Macaca fascicularis) by androstenedione and its antagonization by the aromatase inhibitor 1-methyl-androsta-1,4-diene-3,1 7-dione. Prostate. 1987;1:313-326
59. Reeder BM, Rai A, Patel DR, Cucos D, Smith F. The prevalence of nutritional supplement use among high school students: a pilot study. Med Sci Sports Exerc. 2002;34(suppl 1):S193
60. Rosen CJ. Growth hormone and aging. Endocrine. 2000;12:197-201
61. Rogol AD. Sex steroid and growth hormone supplementation to enhance performance in adolescent athletes. Curr Opin Pediatr. 2000;12:382-387
62. Frisch H. Growth hormone and body composition in athletes. J Endocrinol Invest. 1999;22(suppl):106-109
63. Taafee DR, Pruitt L, Reim J, et al. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men. J Clin Endocrinol Metab. 1994;79:1361-1366
64. Yarasheski KE. Growth hormone effects on metabolism, body composition, muscle mass, and strength. Exerc Sport Sci Rev. 1994;22:285-312
65. Khaleeli AA, Levy RD, Edwards RH, et al. The neuromuscular features of acromegaly: a clinical and pathological study. J Neurol Neurosurg Psychiatry. 1984;47:1009-1115
66. Colao A, Cuocolo A, Marzullo P, et al. Is the acromegalic cardiomyopathy reversible? Effect of 5 year normalization of growth hormone and insulin like growth factor I levels on cardiac performance. J Clin Endocrinol Metab. 2001;86:1551-1557
67. Rennie MJ. Claims for the anabolic effects of growth hormone: a case of the emperor's new clothes? Br J Sports Med. 2003;37:100-105
68. Herbal Rx. The promise and pitfalls. Consumer Reports. 1999:44-48
69. Zorpette G. The mystery of muscle. Sci Am. 1999;10:48-55
70. Burns RD, Schiller MR, Merrick MA, Wolf KN. Intercollegiate student athlete use of nutritional supplements and the role of athletic trainers and dietitians in nutrition counseling. J Am Diet Assoc. 2004;104:246-249
71. Kayton S, Cullen RW, Memken JA, Rutter R. Supplement and ergogenic aid use by competitive male and female high school athletes. Med Sci Sports Exerc. 2002;35(suppl):S193
72. Dietary Supplement Health and Education Act of 1994, Pub L No. 103-417 (October 25, 1994)
73. Green GA, Catlin DH, Starcevic B. Analysis of over the counter dietary supplements. Clin J Sports Med. 2001;11:254-259
74. Balsom PE, Soderlund K, Ekblom B. Creatine in humans with special reference to creatine supplementation. Sports Med. 1994;18:268-280
75. Clark JF. Creatine and phosphocreatine: a review of their use in exercise and sport. J Athl Train. 1997;32:45-51
76. Jenkins MA. Creatine Supplementation in Athletes: Review. SportsMed Web; 1998. Available at: www.rice.edu/~jenky/sports/creatine.html. Accessed January 20, 2006
77. Greenhaff PL, Bodin K, Soderlund K, Hultman E. Effect of oral creatine supplementation on skeletal muscle phosphocreatine resynthesis. Am J Physiol. 1994;66:E725-E730
78. Harris RC, Soderlund K, Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci. 1992;83:367-374
79. Terjung RL, Clarkson P, Eichner ER, Greenhaff PL, Hespel PJ, Israel RG, Kraemer WJ, Meyer RA, Spriet LL, Tarnopolsky MA, Wagenmakers AJ, Williams MH. American College of Sports Medicine roundtable. The physiological and health effects of oral creatine supplementation. Med Sci Sports Exerc. 2000;32:706-717
80. Clark JF. Creatine: a review of its nutritional applications in sport. Nutrition. 1998;14:322-324
81. PDR Health. Creatine. Available at: www.pdrhealth.com/drug_info/ nmdrugprofiles/nutsupdrugs/cre_0086.shtml. Accessed January 20, 2006
82. Green AL, Hultman E, Macdonald IA, et al. Carbohydrate ingestion augments skeletal muscle creatine accumulation during creatine supplementation in humans. Am J Physiol. 1997;271:E821-E826
83. Vandenberghe K, Gillis N, Van Leemputte M, et al. Caffeine counteracts the ergogenic action of muscle creatine loading. J Appl Physiol. 1996;80:452-457
84. Engelhardt M, Neuman G, Berbalk A, Reuter I. Creatine supplementation in endurance sports. Med Sci Sports Exerc. 1998;30:1123-1129
85. Volek JS, Duncan ND, Mazzetti SA, et al. Performance and muscle fiber adaptations to creatine supplementation and heavy resistance training. Med Sci Sports Exerc. 1999;31:1147-1156
86. Pritchard NR, Kaira PA. Renal dysfunction accompanying oral creatine supplements. Lancet. 1998;351:1252-1253
87. Koshy KM, Griswold E, Schneeberger EE. Interstitial nephritis in a patient taking creatine. N Engl J Med. 1999;340:814-815
88. Poortmans JR, Francaux M. Long-term oral creatine supplementation does not impair renal function in healthy athletes. Med Sci Sports Exerc. 1999;31:1108-1110
89. Smith J, Dahm DL. Creatine use among select population of high school athletes. Mayo Clin Proc. 2000;75:1257-1263
90. Metzl JD, Levine SR, Gershel JC. Creatine use among young athletes. Pediatrics. 2001;108:421-425
91. Sallis RE, Jones K. Dietary supplement use among college football players. Med Sci Sports Exerc. 1999;31(suppl):S118
92. Hoffman BB, Lefkowitz RJ. Catecholamines, sympathomimetic drugs and adrenergic receptor antagonists. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's the Pharmacological Basis of Therapeutics. New York, NY: McGraw-Hill; 1996:221-224
93. Bents RT, Tokish JM, Goldberg L. Ephedrine, pseudoephedrine, and amphetamine prevalence in college hockey players. Curr Sports Med Rep. 2004;3:243-245
94. Greydanus DE, Patel DR. Sports doping in the adolescent athlete: the hope, hype, and hyperbole. Pediatr Clin North Am. 2002;49:829-855
95. New drug status of OTC combination drug products containing caffeine. Phenylpropanolamine and ephedrine. Fed Regist. 1982;47:35;344-355
96. Gill ND, Shield A, Blazevich AJ, et al. Muscular and cardiorespiratory effects of pseudoephedrine in human athletes. Br J Clin Pharmacol. 2000;50:205-213
97. Bell DG, McLellan TM, Sabiston CM. Effect of ingesting caffeine and ephedrine on 10 km run performance. Med Sci Sports Exerc. 2002;34:344-349
98. Bent S, Tiedt TN, Odden MC, Shlipak MG. The relative safety of ephedra compared with other herbal products. Ann Intern Med. 2003;138:468-471
99. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000;343:1833-1888
100. National Federation of State High School Associations. Sports medicine: high school drug-testing programs; August 2003. Available at: www.nfhs.org. Accessed January 20, 2006
101. President Bush. State of Union Address to Joint Session of Congress. January 20, 2004
102. Goldberg L, Elliot D, Clarke GN, et al. Effects of a multidimensional anabolic steroid prevention intervention: the adolescents training and learning to avoid steroids (ATLAS) program. JAMA. 1996;276:1555-1562
103. Goldberg L, MacKinnon D, Elliot DL, et al. Preventing drug use and promoting health behaviors among adolescents: results of the ATLAS program. Arch Pediatr Adolesc Med. 2000;154:332-338
104. Elliot DL, Goldberg L, Moe EL, DeFrancesco CA, Durham MB, Hix-Small H. Preventing substance use and disordered eating: initial outcomes of the ATHENA (athletes targeting healthy exercise and nutrition alternatives) program. Arch Pediatr Adolesc Med. 2004;158:1043-1049
105. Goldberg L, Bents R, Bosworth E, et al. Anabolic steroid education and adolescents: do scare tactics work? Pediatrics. 1991;87:283-286